Processing 00000000.tx.1: Wild-type but Not Parkinson's Disease-related Ala-53 Thr Mutant -Synuclein Protects Neuronal Cells from Apoptotic Stimuli* Cristine Alves da Costa, Karine Ancolio, and Frdric Checler From the Institut de Pharmacologie Molculaire et Cellulaire du CNRS, UPR411, 660Route des Lucioles, Sophia Antipolis, 06560Valbonne, France Received for publication, March 22,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Recent works suggest that -synuclein could play a central role in Parkinson's disease (PD). 

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "Not Parkinson's Disease-related Ala-53 Thr Mutant -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Protects"

Phrase: "Neuronal Cells from Apoptotic Stimuli"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   809   C1660771:neuronal cell apoptosis [Cell Function]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "* Cristine Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0035561:Costa [Body Part, Organ, or Organ Component]
   719 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "Karine Ancolio,"

Phrase: "and"

Phrase: "Frdric Checler From the Institut de Pharmacologie Molculaire et Cellulaire du CNRS,"

Phrase: "UPR411,"

Phrase: "660Route des Lucioles,"

Phrase: "Sophia Antipolis,"

Phrase: "06560Valbonne,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 22,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recent works"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:works [Occupational Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(PD"

Phrase: ")."
Processing 00000000.tx.2: Thus, two mutations were reported to be associated with rare autosomal dominant forms of the disease. 

Phrase: "Thus,"

Phrase: "two mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with rare autosomal dominant forms of the disease."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C0443147:Autosomal dominant [Intellectual Product]
   762   C0243083:associated disease [Pathologic Function]
   762   C0678236:Rare Disease [Disease or Syndrome]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C0521114:Rare [Temporal Concept]
   742   C0522498:Rare [Qualitative Concept]
   742   C0596142:autosomal [Cell Component]
   742   C1514917:RARE [Gene or Genome]
   742   C1527180:Dominant [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1522492:Form [Functional Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.3: We examined whether -synuclein could modulate the caspase-mediated response and vulnerability of murine neurons in response to various apoptotic stimuli. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the caspase-mediated response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0870868:mediated response [Mental Process]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "vulnerability of murine neurons"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to various apoptotic stimuli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.4: We established TSM1 neuronal cell lines overexpressing wild-type (wt) -synuclein or the PD-related Ala-53 Thr mutant -synuclein. 

Phrase: "We"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "TSM1 neuronal cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   741 E C0027882:Neuron [Cell]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type (wt) -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "the PD-related Ala-53 Thr mutant -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.5: Under basal conditions, acetyl-Asp-Glu-Val-Asp-aldehyde-sensitive caspase activity appears significantly lower in wt -synuclein-expressing cells than in neurons expressing the mutant. 

Phrase: "Under basal conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "acetyl-Asp-Glu-Val-Asp-aldehyde-sensitive caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   807   C1150130:caspase activity [Molecular Function]
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "significantly lower in wt -synuclein-expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "the mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.6: Interestingly, wt -synuclein drastically reduces the caspase activation of TSM1 neurons upon three distinct apoptotic stimuli including staurosporine, etoposide, and ceramide C2 when compared with mock-transfected cells. 

Phrase: "Interestingly,"

Phrase: "wt -synuclein drastically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reduces"

Phrase: "the caspase activation of TSM1 neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1159825:Caspase Activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "upon three distinct apoptotic stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0234402:Stimuli [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "ceramide C2"

Phrase: "when"

Phrase: "compared with mock-transfected cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0562577:mock [Finding]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: This inhibitory control of the caspase response triggered by apoptotic agents was abolished by the PD-related pathogenic mutation. 

Phrase: "This inhibitory control of the caspase response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C3274768:Inhibitory Control [Cell Function]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3463820:Inhibitory [Activity]

Phrase: "triggered by apoptotic agents"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1444748:Triggered by [Qualitative Concept]
           Trigger
   770   C1516044:Apoptotic [Qualitative Concept]
   737   C0032930:Trigger [Clinical Attribute]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "was"

Phrase: "abolished by the PD-related pathogenic mutation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0026882:Mutation [Genetic Function]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0450254:Pathogenic [Organism]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.8: Comparison of wild-type and mutated -synuclein-expressing cells also indicates that the former exhibits much less vulnerability in response to staurosporine and etoposide as measured by the sodium 3'-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzenesulfonic acid assay. 

Phrase: "Comparison of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synuclein-expressing cells also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the former exhibits much less vulnerability in response"

Phrase: "to staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "measured by the sodium 3'-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0444706:Measured [Qualitative Concept]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "[1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(phenylaminocarbonyl"

Phrase: ")-"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4-tetrazolium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "]-bis(4-methoxy-6-nitro"

Phrase: ")"

Phrase: "benzenesulfonic acid assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0053170:benzenesulfonic acid [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.9: Altogether, our study indicates that wild-type -synuclein exerts an antiapoptotic effect in neurons that appears to be abolished by the Parkinson's disease-related mutation, thereby suggesting a possible mechanism underlying both sporadic and familial forms of this neurodegenerative disease.  

Phrase: "Altogether,"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "indicates"

Phrase: "that wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "an antiapoptotic effect in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "abolished by the Parkinson's disease-related mutation,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0026882:Mutation [Genetic Function]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "thereby"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a possible mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "both sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "familial forms of this neurodegenerative disease."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C1832428:Familial form [Finding]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Parkinson's disease neuropathology is mainly characterized by proteinaceous deposits called Lewy bodies (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease neuropathology"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   827   C1540677:neuropathology [Pathologic Function]
   827   C1555824:Neuropathology [Intellectual Product]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "is"

Phrase: "mainly"

Phrase: "characterized by proteinaceous deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333562:Deposits [Functional Concept]
   770   C1880022:Characterized [Activity]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: The main component of these brain lesions is -synuclein (2, 3), a 140-amino acid peptide first identified as the precursor of the "non-amyloidogenic component" (4) of the senile plaques invading the cortical and subcortical areas of both sporadic and familial Alzheimer's disease-affected brains. 

Phrase: "The main component of these brain lesions is -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]
   720   C1563245:Lesioned component [Finding]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a 140-amino acid peptide first"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "identified as the precursor of the ""non-amyloidogenic component"""
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205396:Identified [Qualitative Concept]
   742   C0449432:Component [Manufactured Object]
   742   C1518422:Non [Functional Concept]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]
   742   C1705248:Component [Conceptual Entity]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "(4"

Phrase: ")"

Phrase: "of the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "invading"

Phrase: "the cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0001613:Cortical [Body Part, Organ, or Organ Component]
  1000   C0007776:Cortical [Body Part, Organ, or Organ Component]
  1000   C0022655:Cortical [Body Part, Organ, or Organ Component]
   944 E C0234875:bark [Organism Attribute]
   944 E C2700441:Bark [Plant]
   916 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   916 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "subcortical areas of both sporadic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "and"

Phrase: "familial Alzheimer's disease-affected brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0006104:Brains [Body Part, Organ, or Organ Component]
   771 E C1269537:Brain [Body Part, Organ, or Organ Component]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]
Processing 00000000.tx.12: Of the most interest was the recent demonstration that rare cases of Parkinson's disease were of genetic origin and that two mutations identified on -synuclein were likely responsible for these autosomal forms of the disease (5, 6). 

Phrase: "Of the most interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "was"

Phrase: "the recent demonstration"

Phrase: "that rare cases of Parkinson's disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "were of genetic origin"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "that two mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "on -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "likely responsible for these autosomal forms of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.13: It has been suggested that part of the disease etiology is derived from the accelerated aggregation process triggered by the two mutations (7). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that part of the disease etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "is"

Phrase: "derived from the accelerated aggregation process"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C0521110:Accelerated [Functional Concept]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C1522240:Process [Phenomenon or Process]
   753   C3245521:derived [Idea or Concept]

Phrase: "triggered by the two mutations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1444748:Triggered by [Qualitative Concept]
           Trigger
   760   C0026882:Mutations [Genetic Function]
   760   C0205448:Two [Quantitative Concept]
   726   C0032930:Trigger [Clinical Attribute]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.14: El Agnaf et al. 

Phrase: "El Agnaf et al."
Processing 00000000.tx.15: (8) showed that -sheets-related aggregates of wild-type and mutant -synucleins could trigger apoptotic cell death in human neuroblastoma cells. 

Phrase: "(8"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -sheets-related aggregates of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "mutant -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptotic cell death in human neuroblastoma cells."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0162638:apoptotic cell death [Cell Function]
   778   C0007587:Cell Death [Cell Function]
           cells death
   774   C0427861:cell human [Laboratory or Test Result]
   774   C0815000:neuroblastoma cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.16: More recently, Kholodilov et al. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "Kholodilov et al."
Processing 00000000.tx.17: (9) demonstrated that -synuclein expression was decreased in the rat substantia nigra after induction of apoptosis by intrastriatal injection of 6-hydroxydopamine. 

Phrase: "(9"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that -synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "decreased in the rat substantia nigra"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   790   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "after induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "by intrastriatal injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of 6-hydroxydopamine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085196:6-Hydroxydopamine [Organic Chemical,Pharmacologic Substance]
   861   C0205795:Hydroxydopamine [Organic Chemical]
Processing 00000000.tx.18: Although these two studies established a possible link between -synucleins and apoptosis, nothing is really known concerning the genuine function of -synuclein. 

Phrase: "Although"

Phrase: "these two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a possible link between -synucleins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "nothing"

Phrase: "is"

Phrase: "really"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the genuine function of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.19: We have taken advantage of the design of a clonal cell line from neocortical origin (TSM1 cells (10)) to examine the possible influence of -synuclein in the control of the neuronal apoptotic response and to establish a putative modulation of such a function by the Parkinson's disease pathogenic mutation. 

Phrase: "We"

Phrase: "have"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "advantage of the design of a clonal cell line"

Phrase: "from neocortical origin"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]

Phrase: "(TSM1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the possible influence of -synuclein in the control of the neuronal apoptotic response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a putative modulation of such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "a function by the Parkinson's disease pathogenic mutation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
Processing 00000000.tx.20: We set up TSM1 neurons stably overexpressing wild-type -synuclein or its Parkinson's disease-associated Ala-53 Thr mutant to examine their caspase response to various apoptotic stimuli. 

Phrase: "We set up TSM1 neurons stably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "its Parkinson's disease-associated Ala-53 Thr mutant to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "examine"

Phrase: "their caspase response to various apoptotic stimuli."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0424540:Response to stimulus [Mental Process]
   793   C0542478:response to stimulus [Physiologic Function]
           stimulus/response
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.21: We show here that wild-type -synuclein displays antiapoptotic properties that are abolished by the Parkinson's disease-related mutation.  

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "antiapoptotic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "that"

Phrase: "are"

Phrase: "abolished by the Parkinson's disease-related mutation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0026882:Mutation [Genetic Function]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.22: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein Cloning and Mutagenesis-- A cDNA library was prepared from total RNA derived from human adult cortex. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES -Synuclein Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "Mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079866:Mutagenesis [Molecular Function]
  1000   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "A cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from total RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "derived from human adult cortex."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C0001675:Human, Adult [Age Group]
           Adult
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1441547:Derived [Qualitative Concept]
   760   C1706450:Adult [Human]
   760   C2700441:Cortex [Plant]
   760   C3245521:derived [Idea or Concept]
Processing 00000000.tx.23: A polymerase chain reaction product was obtained by means of the following primers, 5'-CGCAAGCTTAGGAATTCATTAGCCATGGATGTATTCAT-3' containing the HindIII restriction site and 5'-TTTCTCGAGTATTTCTTAGGCTTCAGGTTCGTAGTC-3' containing the XhoI site. 

Phrase: "A polymerase chain reaction product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "obtained by means of the following primers,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   748   C1301820:Obtained [Functional Concept]
   748   C1704970:Means [Conceptual Entity]
   714   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   714   C0332283:follow [Temporal Concept]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C1706701:Obtain [Activity]
   714   C1719822:Follow [Intellectual Product]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]

Phrase: "5'-CGCAAGCTTAGGAATTCATTAGCCATGGATGTATTCAT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the HindIII restriction site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "5'-TTTCTCGAGTATTTCTTAGGCTTCAGGTTCGTAGTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the XhoI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.24: The polymerase chain reaction fragment was cut with HindIII and XhoI and then subcloned in pcDNA3, and the identity of -synuclein was confirmed by entire sequencing analysis (11). 

Phrase: "The polymerase chain reaction fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "cut with HindIII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000925:Cut [Injury or Poisoning]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "XhoI"

Phrase: "and"

Phrase: "then subcloned in pcDNA3,"

Phrase: "and"

Phrase: "the identity of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "confirmed by entire sequencing analysis"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0439751:Entire [Quantitative Concept]
   760   C0444667:Entire [Quantitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162326:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.25: The Ala-53 Thr mutation was introduced according to the uracylated single strand strategy as described previously (12) and confirmed by sequencing. 

Phrase: "The Ala-53 Thr mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "introduced according to the uracylated single strand strategy"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1979975:Single strand [Qualitative Concept]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0679199:strategy [Mental Process]
   744   C0680240:according [Social Behavior]
   744   C1704972:Strand [Spatial Concept]
   744   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   711   C1292748:introduce [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.26: TSM1 Culture and Stable Transfection-- TSM1 neuronal cells were cultured as described (13). 

Phrase: "TSM1 Culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Stable Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "TSM1 neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured as described"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1552738:described [Idea or Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.27: TSM1 cells were stably transfected with superfect agent (Qiagen) containing 2g of pcDNA3 vector either empty or encoding wild-type or Ala-53 Thr -synucleins. 

Phrase: "TSM1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with superfect agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450442:Agent [Chemical Viewed Functionally]
   770   C1254351:Agent [Pharmacologic Substance]
   770   C1521826:Agent [Intellectual Product]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: "containing 2g of pcDNA3 vector"

Phrase: "either empty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880497:Empty [Qualitative Concept]

Phrase: "or"

Phrase: "encoding wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "Ala-53 Thr -synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.28: Transfectants were screened by Tris-Tricine1 gel analysis and Western blotting (see below). 

Phrase: "Transfectants"

Phrase: "were"

Phrase: "screened by Tris-Tricine1 gel analysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]
   753   C0936012:Analysis [Research Activity]
   753   C1382104:Gel [Substance]
   753   C1524024:analysis [Functional Concept]
   719   C0220908:screen [Health Care Activity]
   719   C1305399:screen [Functional Concept]
   719   C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.29: Positive clones overexpress a 18-19-kDa immunoreactive protein in agreement with a previous study (4). 

Phrase: "Positive clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "a 18-19-kDa immunoreactive protein in agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0054966:Protein 18 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with a previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.30: Tris-Tricine Gel Analysis and Western Blots-- TSM1 cells were scraped and lysed in RIPA 1 buffer (10mM Tris, pH 7.5,containing 150mM NaCl, 5mM EDTA, 0.1% SDS, 0.5% deoxycholate, and 1% Nonidet P-40), and then proteins were analyzed by a 16.5% Tris-Tricine gel electrophoresis and Western blotted as described (13). 

Phrase: "Tris-Tricine Gel Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Western Blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "TSM1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "scraped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184933:scraped [Therapeutic or Preventive Procedure]
  1000   C0444082:scraped [Body Substance]

Phrase: "and"

Phrase: "lysed in RIPA 1 buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0034584:RIPA [Laboratory Procedure]

Phrase: "(10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1% SDS,"

Phrase: "0.5% deoxycholate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "analyzed by a 16.5% Tris-Tricine gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0596607:Gel Electrophoresis [Laboratory Procedure]
   762 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   742   C0013855:Electrophoresis [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077068:tricine [Organic Chemical]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0814229:TRI [Intellectual Product]
   742   C0936012:Analyzed [Research Activity]
   742   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: Nitrocellulose sheets were heated in boiling phosphate buffer and then capped with 5% skim milk in phosphate-buffered saline. 

Phrase: "Nitrocellulose sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439643:Sheets [Spatial Concept]
   827 E C2349187:Sheet [Quantitative Concept]

Phrase: "were"

Phrase: "heated in boiling phosphate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C0018837:Heat [Natural Phenomenon or Process]
   726   C0242301:Boil [Disease or Syndrome]
   726   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "capped with 5% skim milk"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0349375:Skim milk [Food]
   760   C0026131:Milk [Body Substance]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   726   C0179586:Cap [Manufactured Object]
   726   C1657858:CAP [Medical Device]
   726   C1706092:Cap [Medical Device]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.32: Membranes were then rinsed and incubated with a 1/5000 dilution of anti-human -synuclein (SA3400 from Affiniti). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated with a 1/5000 dilution of anti-human -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0079240:Dilution [Laboratory Procedure]
   739   C0086418:Human [Human]
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1948037:Dilution [Functional Concept]

Phrase: "(SA3400 from Affiniti"

Phrase: ")."
Processing 00000000.tx.33: Membranes were then incubated with protein A coupled to peroxidase (2g/ml), and then immunological complexes were revealed by ECL (Amersham Pharmacia Biotech) as described previously (13). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with protein A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "coupled to peroxidase"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "(2g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then immunological complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "revealed by ECL (Amersham Pharmacia Biotech"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0331955:Pharmacia [Health Care Related Organization]
   753   C0443289:Revealed [Qualitative Concept]
   753   C1332684:ECL [Gene or Genome]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.34: Measurements of Ac-DEVD-al-sensitive Caspase Activity-- TSM1 cells were cultured in 12-well plates for various times at 37C in the absence or in the presence of various concentrations of etoposide, ceramide C2, or staurosporine. 

Phrase: "Measurements of Ac-DEVD-al-sensitive Caspase Activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0242485:measurements [Functional Concept]

Phrase: "--"

Phrase: "TSM1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in 12-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "plates for various times"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0005971:Plate [Medical Device]
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1139930:plate [Medical Device]
   770   C1632851:Times [Quantitative Concept]
   770   C3537155:Plate [Manufactured Object]
   737 E C3541383:Time [Temporal Concept]

Phrase: "at 37C"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or in the presence of various concentrations of etoposide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   742   C0086045:Concentrations [Mental Process]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "ceramide C2,"

Phrase: "or"

Phrase: "staurosporine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.35: In some cases, cells were incubated with 100M Ac-DEVD-al for 24h. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with 100M Ac-DEVD-al"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1412573:AC [Gene or Genome]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3539770:AC [Gene or Genome]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.36: Cells were then rinsed, gently scraped, pelleted by centrifugation, and then resuspended in 40l of lysis buffer (25mM Hepes, pH 7.5,containing 5mM MgCl2, and dithiothreitol, 2mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 10g/ml pepstatin A, and leupeptin). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: ","

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "scraped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184933:scraped [Therapeutic or Preventive Procedure]
  1000   C0444082:scraped [Body Substance]

Phrase: ","

Phrase: "pelleted by centrifugation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in 40l of lysis buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:Lysis [Pathologic Function]
   753   C1536403:lysis [Cell Function]

Phrase: "(25mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "2mM 4-"

Phrase: "(2-aminoethyl"

Phrase: ")"

Phrase: "benzenesulfonyl fluoride,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10g/ml pepstatin A,"

Phrase: "and"

Phrase: "leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.37: Cell lysates were submitted to two freezing/thawing cycles and then centrifuged (16,000g for 5min). 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "submitted to two freezing/thawing cycles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0016701:Freezing [Natural Phenomenon or Process]
   753   C0205448:Two [Quantitative Concept]
   753   C1515023:Submitted [Functional Concept]
   719   C1511572:Cycle [Temporal Concept]
   719   C1710378:Thaw [Laboratory Procedure]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(16,"

Phrase: "000g for 5min"

Phrase: ")."
Processing 00000000.tx.38: Caspase activity of supernatants (10l, about 50g of proteins) was measured in 96-well plates according to manufacturer's recommendations (Promega). 

Phrase: "Caspase activity of supernatants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1150130:caspase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(10l,"

Phrase: "about 50g"

Phrase: "of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "was"

Phrase: "measured in 96-well"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205170:Well [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "plates according to manufacturer's recommendations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C0150600:Recommendation to [Health Care Activity]
   760   C0005971:Plate [Medical Device]
   760   C0034866:recommendations [Idea or Concept]
   760   C0680240:according [Social Behavior]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1139930:plate [Medical Device]
   760   C1705426:Manufacturer [Population Group]
   760   C3537155:Plate [Manufactured Object]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.39: Briefly, reaction mixtures containing 48l of water, 32l of assay buffer (312mM Hepes, pH 7.5,31.25% sucrose, 0.31% Chaps), 10l of 100mM dithiothreitol, and 2l of Me2SO were incubated for various times with 2l of 2.5mM Ac-DEVD-AMC (caspase substrate). 

Phrase: "Briefly,"

Phrase: "reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "48l of water,"

Phrase: "32l of assay buffer"

Phrase: "(312mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "31.25% sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "0.31% Chaps"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   793 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "10l of 100mM dithiothreitol,"

Phrase: "and"

Phrase: "2l of Me2SO"

Phrase: "were"

Phrase: "incubated for various times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "with 2l"

Phrase: "of 2.5mM Ac-DEVD-AMC (caspase substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1710236:Substrate [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.40: In some assays, proteins were preincubated for 30min at 37C in the absence or in the presence of 2l of Ac-DEVD-al (2.5mM). 

Phrase: "In some assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "preincubated for 30min"

Phrase: "at 37C"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or in the presence of 2l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "of Ac-DEVD-al (2.5mM"

Phrase: ")."
Processing 00000000.tx.41: Fluorimetry was recorded at 360and 460nm for excitation and emission wavelengths, respectively. 

Phrase: "Fluorimetry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016352:Fluorimetry [Laboratory Procedure]

Phrase: "was"

Phrase: "recorded at 360and 460nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0034869:Record [Intellectual Product]

Phrase: "for excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelengths,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:wavelengths [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.42: Caspase-specific activity was calculated from the linear part of fluorimetry recording and expressed in arbitrary units/h/mg or proteins (established by the Bio-Rad procedure). 

Phrase: "Caspase-specific activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "calculated from the linear part of fluorimetry recording"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1292711:Part of [Spatial Concept]
   744   C0016352:Fluorimetry [Laboratory Procedure]
   744   C0205132:Linear [Spatial Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "expressed in arbitrary units/h/mg"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   783   C0439421:mg/h [Quantitative Concept]
   767   C1638407:Unit/mg [Quantitative Concept]
   756   C0439183:Arbitrary unit [Quantitative Concept]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439148:Units [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1264693:*Arbitrary [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "or"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "established by the Bio-Rad procedure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: One arbitrary unit corresponds to 4nmol of AMC released. 

Phrase: "One arbitrary unit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439183:Arbitrary unit [Quantitative Concept]
   827   C0439148:Unit [Quantitative Concept]
   827   C1264693:*Arbitrary [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "corresponds to 4nmol of AMC"

Phrase: "released."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.44: Cell Viability-- TSM1 neurons were grown in a 6.5% CO2 atmosphere in 96-well microtiter plates in a 100-l culture medium (see above) and treated with 100M etoposide or 1M staurosporine for 24h at 37C. 

Phrase: "Cell Viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "grown in a 6.5% CO2 atmosphere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0004178:Atmosphere [Natural Phenomenon or Process]
   748   C0678214:atmosphere [Quantitative Concept]
   748   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "in 96-well microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1709027:Microtiter Plate [Research Device]
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "in a 100-l culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Medium [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C2242979:Culture [Laboratory Procedure]
   812   C3244283:medium [Intellectual Product]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "treated with 100M etoposide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "1M staurosporine for 24h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "at 37C."
Processing 00000000.tx.45: XTT-metabolizing activity was determined mainly according to the manufacturer's recommendations (Roche Molecular Biochemicals). 

Phrase: "XTT-metabolizing activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "mainly according to the manufacturer's recommendations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0150600:Recommendation to [Health Care Activity]
   753   C0034866:recommendations [Idea or Concept]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1705426:Manufacturer [Population Group]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")."
Processing 00000000.tx.46: Briefly, after cell treatment, 50l of XTT labeling mixture was added to each well and further incubated at 37C. 

Phrase: "Briefly,"

Phrase: "after"

Phrase: "cell treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "50l of XTT labeling mixture"

Phrase: "was"

Phrase: "added to each well"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated at 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.47: Absorbances were recorded after successive 10-min intervals (for a total time of 60min) and measured at 452nm on a microtiter plate reader (lab system). 

Phrase: "Absorbances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1268822:Absorbance [Clinical Attribute]
   966   C2825050:Absorbance [Phenomenon or Process]

Phrase: "were"

Phrase: "recorded after successive 10-min intervals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0456692:/10 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:intervals [Temporal Concept]
   719   C0034869:Record [Intellectual Product]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: "("

Phrase: "for a total time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of 60min"

Phrase: ")"

Phrase: "and"

Phrase: "measured at 452nm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "on a microtiter plate reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514743:Reader [Professional or Occupational Group]
   827   C1706461:Reader [Manufactured Object]
   734   C1709027:Microtiter Plate [Research Device]

Phrase: "(lab system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.48: Statistics-- Statistically analyses were performed with PRISM software (Graphpad Software, San Diego, CA) using the Newman Keuls multiple comparison test for one-way analysis of variance. 

Phrase: "Statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "--"

Phrase: "Statistically analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed with PRISM software"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0814195:PRISM [Intellectual Product]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
   715 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(Graphpad Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Newman Keuls multiple comparison test for one-way analysis of variance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0022885:Test [Laboratory Procedure]
   736   C0039593:Test [Functional Concept]
   736   C0392366:test [Intellectual Product]
Processing 00000000.tx.49: Materials-- Ac-DEVD-AMC and Ac-DEVD-al were purchased from Neosystem. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Ac-DEVD-AMC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0674974:Ac-DEVD-AMC [Amino Acid, Peptide, or Protein]
   901   C0532119:DEVD-AMC [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ac-DEVD-al"

Phrase: "were"

Phrase: "purchased from Neosystem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.50: Anti-human -synuclein (SA3400) was from Affiniti. 

Phrase: "Anti-human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SA3400"

Phrase: ")"

Phrase: "was from Affiniti."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.51: XTT kit was from Roche Molecular Biochemicals. 

Phrase: "XTT kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0812225:KIT [Medical Device]
   861   C1150635:KIT [Molecular Function]
   861   C1705212:Kit [Medical Device]
   861   C1705213:KIT [Medical Device]
   861   C3273202:Kit [Manufactured Object]

Phrase: "was from Roche Molecular Biochemicals."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0331965:Roche [Health Care Related Organization]
   760   C1421478:WAS [Gene or Genome]
   760   C1521991:Molecular [Qualitative Concept]
   726   C0205474:Biochemical [Functional Concept]
Processing 00000000.tx.52: Etoposide, staurosporine, protease inhibitors, and protein A-peroxidase were from Sigma. 

Phrase: "Etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "protein A-peroxidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.53: Ceramide C2 was from Biomol. 

Phrase: "Ceramide C2"

Phrase: "was from Biomol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.54: ECL was from Amersham Pharmacia Biotech.  

Phrase: "ECL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "was from Amersham Pharmacia Biotech."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0331955:Pharmacia [Health Care Related Organization]
   760   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.55: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Mock-transfected TSM1 neurons were examined for the modulation of their caspase activity in response to various apoptotic stimuli. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "examined for the modulation of their caspase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1150130:caspase activity [Molecular Function]
   744   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0332128:Examined [Finding]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0443264:Modulation [Spatial Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to various apoptotic stimuli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.56: In basal conditions, TSM1 neurons display an Ac-DEVD-7AMC hydrolyzing activity that is virtually fully abolished by prior treatment with the caspase inhibitor, Ac-DEVD-al (Fig. 1, N.St). 

Phrase: "In basal conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "an Ac-DEVD-7AMC hydrolyzing activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "virtually fully"

Phrase: "abolished by prior treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1514463:Prior Treatment [Clinical Attribute]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0332152:Prior [Temporal Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2826257:PRIOR [Event]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with the caspase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "Ac-DEVD-al (Fig. 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0380301:AL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C1412573:AC [Gene or Genome]
   804   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   804   C3539770:AC [Gene or Genome]

Phrase: "N.St)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.57: Ac-DEVD-al-sensitive activity was drastically enhanced after treatment of mock-transfected TSM1 neurons with staurosporine, etoposide, and ceramide-C2 (Fig. 1), three classical pro-apoptotic effectors. 

Phrase: "Ac-DEVD-al-sensitive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "drastically"

Phrase: "enhanced after treatment of mock-transfected TSM1 neurons"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0001758:After-Treatment [Health Care Activity]
   744   C0027882:Neurons [Cell]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0562577:mock [Finding]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C2349975:Enhanced [Activity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "with staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "ceramide-C2 (Fig. 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1695071:CERAMIDE 1 [Lipid,Pharmacologic Substance]
   812   C0007745:Ceramide [Biologically Active Substance,Lipid]
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "three classical pro-apoptotic effectors."
Processing 00000000.tx.58: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.59: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.60: Ac-DEVD-al-sensitive caspase activity in mock-transfected TSM1 neurons, effect of apoptotic stimuli. 

Phrase: "Ac-DEVD-al-sensitive caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1150130:caspase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "in mock-transfected TSM1 neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "effect of apoptotic stimuli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.61: Mock-transfected TSM1 neurons were cultured without (black bars) or with (hatched bars) Ac-DEVD-al in the absence (N.St) or in the presence of staurosporine (STS, 1M, 2h), etoposide (ETO, 50M, 24h), or ceramide C2 (CER, 100M, 24h). 

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "cultured without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "(black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or with"

Phrase: "(hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "Ac-DEVD-al in the absence"

Phrase: "(N.St)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "or in the presence of staurosporine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(STS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037556:STS [Lipid,Pharmacologic Substance]

Phrase: "1M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(ETO,"

Phrase: "50M,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "ceramide C2 (CER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0237504:CER [Intellectual Product]

Phrase: "100M,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.62: After cell treatments, caspase activity was assayed as detailed under "Experimental Procedures." 

Phrase: "After cell treatments,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed under ""Experimental Procedures."""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.63: Bars correspond to the Ac-DEVD-al-sensitive Ac-DEVD-AMC hydrolyzing activity and are the meansS.E. of duplicate determinations of 8independent experiments. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "correspond"

Phrase: "to the Ac-DEVD-al-sensitive Ac-DEVD-AMC hydrolyzing activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   704   C0674974:Ac-DEVD-AMC [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "are"

Phrase: "the meansS.E."

Phrase: "of duplicate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "of 8independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.64: We set up stably transfected TSM1 neurons overexpressing wild-type and Ala-53 Thr -synucleins. 

Phrase: "We set up stably transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Ala-53 Thr -synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.65: As expected from the use of antibody specificities against the human species, mock-transfected TSM1 neurons do not display any -synuclein-like immunoreactivity (Fig. 2). 

Phrase: "As"

Phrase: "expected from the use of antibody specificities"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0003264:Specificities, Antibody [Molecular Function]
   778   C1524063:Use of [Functional Concept]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1517001:Expected [Idea or Concept]
   748   C1947944:Use [Intellectual Product]
   732 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   714   C0037791:Specificity [Quantitative Concept]
   714   C1511884:Specificity [Quantitative Concept]

Phrase: "against the human species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "any -synuclein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.66: We obtained several positive clones expressing various levels of an 18-19-kDa immunoreactive protein in agreement with the expected molecular weight of -synuclein (4). 

Phrase: "We"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "several positive clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "various levels of an 18-19-kDa immunoreactive protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0428479:Protein level [Laboratory or Test Result]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the expected molecular weight of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.67: We have selected two clones expressing virtually identical amounts of wild-type (clone T1) and mutated (clone K1) -synucleins (Fig. 2) for further analysis. 

Phrase: "We"

Phrase: "have"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "two clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "virtually identical amounts of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1550420:Amount type [Classification]
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(clone T1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413227:T1 [Gene or Genome]

Phrase: "and"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "(clone K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3272787:K1 [Gene or Genome]

Phrase: ") -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "for further analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.68: View larger version (37K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.69: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.70: -Synuclein-like immunoreactivity in stably transfected TSM1 neurons expressing wild-type and mutated -synucleins. 

Phrase: "-Synuclein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "in stably transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.71: TSM1 neurons were stably transfected with empty pcDNA3 vector (Mock) or with wild-type (T1) or Ala-53 Thr (K1) -synucleins. 

Phrase: "TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with empty pcDNA3 vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]

Phrase: "(Mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: ")"

Phrase: "or with wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "(T1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413227:T1 [Gene or Genome]

Phrase: "or"

Phrase: "Ala-53 Thr (K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C3272787:K1 [Gene or Genome]

Phrase: ") -"

Phrase: "synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.72: -Synuclein-like immunoreactivity (-SYN) of transfectants was analyzed by electrophoresis on a 16.5% Tris-Tricine gel, Western blotted, and incubated with Affiniti antibody as extensively detailed under "Experimental Procedures." 

Phrase: "-Synuclein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(-SYN) of transfectants"

Phrase: "was"

Phrase: "analyzed by electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "on a 16.5% Tris-Tricine gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "incubated with Affiniti antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "as"

Phrase: "extensively"

Phrase: "detailed under ""Experimental Procedures."""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.73: T1 clone exhibits a drastically lower basal Ac-DEVD-al-sensitive caspase activity than mock-transfected cells, suggesting that wild-type -synuclein exerts an inhibitory control on basal caspase activity (Fig. 3). 

Phrase: "T1 clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a drastically"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "basal Ac-DEVD-al-sensitive caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1150130:caspase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "than mock-transfected cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "an inhibitory control on basal caspase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C3274768:Inhibitory Control [Cell Function]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3463820:Inhibitory [Activity]
   738   C1706449:Active Control [Research Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.74: Interestingly, another clone (T6) displaying lower wild-type -synuclein-like immunoreactivity than T1 clone also displays a reduced basal caspase activity, although to a lower extent (not shown). 

Phrase: "Interestingly,"

Phrase: "another clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(T6) displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0870432:displaying [Functional Concept]
   827 E C1705417:Display [Manufactured Object]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "wild-type -synuclein-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "than T1 clone also"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a reduced basal caspase activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0086439:Reduced Activity [Sign or Symptom]
   861   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "although to a lower extent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439792:Extent [Spatial Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: Very strikingly, this inhibitory tonus was not observed with the K1 clone, the basal caspase activity of which resembles that measured in mock-transfected cells (Fig. 3). 

Phrase: "Very strikingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442824:Very [Qualitative Concept]

Phrase: "this inhibitory tonus"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed with the K1 clone,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009013:Clone [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1522642:Clone [Tissue]
   760   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C3272787:K1 [Gene or Genome]

Phrase: "the basal caspase activity of which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1150130:caspase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "resembles"

Phrase: "that"

Phrase: "measured in mock-transfected cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0444706:Measured [Qualitative Concept]
   760   C0562577:mock [Finding]
   760   C3282337:Cells [Cell]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.76: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.77: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.78: Basal caspase activity in TSM1 neurons expressing wild-type and mutated -synucleins. 

Phrase: "Basal caspase activity in TSM1 neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1150130:caspase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.79: Mock-transfected TSM1 neurons or K1 and T1 clones were cultured without (black bars) or with (hatched bars) Ac-DEVD-al in the absence of apoptotic stimuli, and then caspase activity was measured as described under "Experimental Procedures." 

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "or"

Phrase: "K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "and"

Phrase: "T1 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "(black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or with"

Phrase: "(hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "Ac-DEVD-al in the absence of apoptotic stimuli,"

Phrase: "and"

Phrase: "then caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.80: Bars correspond to the Ac-DEVD-al-sensitive Ac-DEVD-AMC hydrolyzing activity and are the meansS.E. of duplicate determinations of 5-8 independent experiments. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "correspond"

Phrase: "to the Ac-DEVD-al-sensitive Ac-DEVD-AMC hydrolyzing activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   704   C0674974:Ac-DEVD-AMC [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "are"

Phrase: "the meansS.E."

Phrase: "of duplicate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "of 5-8 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.81: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 4 indicates that the treatment of T1 and K1 clones with the Ac-DEVD-al did not not modify the -synuclein-like immunoreactivities, indicating that the distinct basal apoptotic caspase-mediated response of K1 and T1 clones could not be accounted for a distinct susceptibility of wild-type and mutated -synucleins to caspase proteolysis. 

Phrase: "4"

Phrase: "indicates"

Phrase: "that"

Phrase: "the treatment of T1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "clones with the Ac-DEVD-al"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009013:Clone [Cell]
   753   C1412573:AC [Gene or Genome]
   753   C1522642:Clone [Tissue]
   753   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3539770:AC [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the -synuclein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597879:immunoreactivity [Molecular Function]

Phrase: "indicating"

Phrase: "that"

Phrase: "the distinct basal apoptotic caspase-mediated response of K1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0870868:mediated response [Mental Process]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "T1 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "accounted for a distinct susceptibility of wild-type"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0012655:Susceptibility [Clinical Attribute]
   744   C0220898:Susceptibility [Organism Attribute]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1264642:Susceptibility [Functional Concept]
   744   C1547045:*Susceptibility [Quantitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   711   C1551359:account [Idea or Concept]
   711   C2741673:Account # [Clinical Attribute]
   711   C2981730:Account [Classification]

Phrase: "and"

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synucleins to caspase proteolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.83: This agrees well with previous studies showing that -synucleins are long-lived proteins in various cell types including PC12 and HEK293 cells (14) and that both wild-type and Ala-53 Thr -synucleins resist proteolysis by the proteasome in TSM1 neurons (11). 

Phrase: "This"

Phrase: "agrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "well with previous studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205156:Previous [Temporal Concept]
   770   C0205170:Well [Qualitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1552607:previous [Temporal Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "long-lived proteins in various cell types"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Ala-53 Thr -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resist"

Phrase: "proteolysis by the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "in TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.84: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.85: 4.  

Phrase: "4."
Processing 00000000.tx.86: Effect of Ac-DEVD-al on -synuclein-like immunoreactivity in TSM1 neurons expressing wild-type and mutated -synucleins. 

Phrase: "Effect of Ac-DEVD-al on -synuclein-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "in TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.87: Mock-transfected TSM1 neurons (Mock) or K1 and T1 clones were cultured without () or with (+) Ac-DEVD-al. 

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "and"

Phrase: "T1 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: ")"

Phrase: "or with"

Phrase: "(+"

Phrase: ")"

Phrase: "Ac-DEVD-al."
Processing 00000000.tx.88: -Synuclein-like immunoreactivity (-SYN) of transfectants was analyzed by electrophoresis on a 16.5% Tris-Tricine gel, Western blotted, and incubated with Affinity antibody as extensively detailed under "Experimental Procedures." 

Phrase: "-Synuclein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(-SYN) of transfectants"

Phrase: "was"

Phrase: "analyzed by electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "on a 16.5% Tris-Tricine gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "incubated with Affinity antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0003255:Antibody Affinity [Molecular Function]
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "extensively"

Phrase: "detailed under ""Experimental Procedures."""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.89: We further examined the caspase activation of TSM1 transfectants upon stimulation by various apoptotic stimuli. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the caspase activation of TSM1 transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1159825:Caspase Activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by various apoptotic stimuli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.90: Table I indicates that T1 clone responsiveness to staurosporine, etoposide, and ceramide C2 was 22-35% of those observed with mock-transfected TSM1 neurons. 

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "indicates"

Phrase: "that T1 clone responsiveness to staurosporine,"

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "ceramide C2"

Phrase: "was"

Phrase: "22-35% of those"

Phrase: "observed with mock-transfected TSM1 neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0027882:Neurons [Cell]
   753   C0562577:mock [Finding]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.91: Here again, the K1 clone displays a caspase response close to that observed with the mock-transfected cells. 

Phrase: "Here again,"

Phrase: "the K1 clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a caspase response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "close to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "observed with the mock-transfected cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0562577:mock [Finding]
   753   C1441672:Observed [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.92: Of most importance was the fact that the Ac-DEVD-7AMC hydrolyzing activities were virtually abolished by Ac-DEVD-al whatever the stimulus examined (Table I). 

Phrase: "Of most importance"

Phrase: "was"

Phrase: "the fact"

Phrase: "that"

Phrase: "the Ac-DEVD-7AMC hydrolyzing activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441655:Activities [Activity]
   771 E C0205177:Activity [Functional Concept]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "virtually"

Phrase: "abolished by Ac-DEVD-al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1412573:AC [Gene or Genome]
   760   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3539770:AC [Gene or Genome]

Phrase: "whatever the stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimulus [Phenomenon or Process]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.93: It should be noted here that apoptotic stimuli do not modify the immunoreactivity of wild-type and -synucleins in TSM1-transfected cells (not shown), excluding the possibility that the distinct responses could be due to a modulation of -synuclein expression by apoptotic agents.  

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "here"

Phrase: "that apoptotic stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the immunoreactivity of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "and -"

Phrase: "synucleins in TSM1-transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the distinct responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "could"

Phrase: "be due to a modulation of -synuclein expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0443264:Modulation [Spatial Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "by apoptotic agents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.94: View this table: [in this window] [in a new window]  Table I Effect of various apoptotic stimuli on the Ac-DEVD-al-sensitive caspase activity of TSM1 transfectants Mock-transfected TSM1 neurons (Mock) and K1 or T1 clones were cultured without () or with (+) Ac-DEVD-al in the absence (basal) or in the presence of stauroporine (STS, 1M, 2h), etoposide (ETO, 50M, 24h) or ceramide C2 (CER, 100M, 24h). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Effect of various apoptotic stimuli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the Ac-DEVD-al-sensitive caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1150130:caspase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "of TSM1 transfectants Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "or"

Phrase: "T1 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: ")"

Phrase: "or with"

Phrase: "(+"

Phrase: ")"

Phrase: "Ac-DEVD-al in the absence"

Phrase: "(basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: ")"

Phrase: "or in the presence of stauroporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(STS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037556:STS [Lipid,Pharmacologic Substance]

Phrase: "1M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(ETO,"

Phrase: "50M,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "ceramide C2 (CER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0237504:CER [Intellectual Product]

Phrase: "100M,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.95: After incubations, caspase activity was assayed as detailed under "Experimental Procedures." corresponds to the Ac-DEVD-al-sensitive Ac-DEVD-AMC-hydrolyzing activity. 

Phrase: "After incubations,"

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed under ""Experimental Procedures."""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "corresponds"

Phrase: "to the Ac-DEVD-al-sensitive Ac-DEVD-AMC-hydrolyzing activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   704   C0674974:Ac-DEVD-AMC [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.96: %are the obtained with T1 and K1 cells expressed as the percent of obtained with mock-transfected TSM1 neurons. 

Phrase: "%"

Phrase: "are"

Phrase: "the"

Phrase: "obtained with T1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1413227:T1 [Gene or Genome]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "K1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressed as the percent of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "obtained with mock-transfected TSM1 neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0027882:Neurons [Cell]
   753   C0562577:mock [Finding]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.97: Values are the meanS.E. of duplicate determinations of 8-12 independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the meanS.E."

Phrase: "of duplicate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "of 8-12 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.98: All apoptotic effectors activate the Ac-DEVD-al-sensitive caspase activity in a dose-dependent manner (Fig. 5). 

Phrase: "All apoptotic effectors"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the Ac-DEVD-al-sensitive caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1150130:caspase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.99: At all concentrations examined, the T1 clone displays a caspase response drastically lower than those exhibited by mock-transfected cells or K1 clone (Fig. 5). 

Phrase: "At all concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "the T1 clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a caspase response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "drastically lower than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "exhibited by mock-transfected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0562577:mock [Finding]
   760   C3282337:Cells [Cell]
   726   C0015272:Exhibit [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "K1 clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.100: Time course analysis of caspase activation upon apoptotic effectors further confirms the much lower Ac-DEVD-al-sensitive activity detectable at any time of the kinetics in cells expressing wild-type -synucleins when compared with other transfectants (Fig. 6). 

Phrase: "Time course analysis of caspase activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C1718396:Time of analysis [Temporal Concept]
   783   C0001282:Activation Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "upon apoptotic effectors further"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the much lower Ac-DEVD-al-sensitive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "detectable at any time of the kinetics"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type -synucleins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "when"

Phrase: "compared with other transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.101: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.103: Dose-response effect of various apoptotic stimuli on the caspase activity of TSM1 transfectants. 

Phrase: "Dose-response effect of various apoptotic stimuli"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0542478:stimulus/response [Physiologic Function]
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1280500:Effect [Qualitative Concept]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2348382:Effect [Qualitative Concept]
   748   C2911692:Response [Mental Process]

Phrase: "on the caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of TSM1 transfectants."
Processing 00000000.tx.104: Mock-transfected TSM1 neurons (triangles), K1 (squares), or T1 (circles) clones were cultured without or with Ac-DEVD-al in the absence or in the presence of the indicated concentrations of staurosporine (STS, 2h), etoposide (ETO, 24h), or ceramide C2 (CER, 24h). 

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "(squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205120:Square [Spatial Concept]
   966   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "T1 (circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "or with Ac-DEVD-al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1412573:AC [Gene or Genome]
   760   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3539770:AC [Gene or Genome]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or in the presence of the indicated concentrations of staurosporine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   739   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   739   C0086045:Concentrations [Mental Process]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1444656:Indicated [Finding]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "(STS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037556:STS [Lipid,Pharmacologic Substance]

Phrase: "2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(ETO,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "ceramide C2 (CER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0237504:CER [Intellectual Product]

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.105: After incubations, caspase activity was assayed as detailed under "Experimental Procedures." 

Phrase: "After incubations,"

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed under ""Experimental Procedures."""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.106: Each point corresponds to the Ac-DEVD-al-sensitive-Ac-DEVD-AMC hydrolyzing activity and is the mean of duplicate determinations of 3independent experiments. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "corresponds"

Phrase: "to the Ac-DEVD-al-sensitive-Ac-DEVD-AMC hydrolyzing activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   704   C0674974:Ac-DEVD-AMC [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "is"

Phrase: "the mean of duplicate determinations of 3independent experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0444504:Mean [Quantitative Concept]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.107: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 6.  

Phrase: "6."
Processing 00000000.tx.109: Time course analysis of various apoptotic stimuli on the caspase activity of TSM1 transfectants. 

Phrase: "Time course analysis of various apoptotic stimuli"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C1718396:Time of analysis [Temporal Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "on the caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of TSM1 transfectants."
Processing 00000000.tx.110: Mock-transfected TSM1 neurons (triangles), K1 (squares), or T1 (circles) clones were cultured without or with Ac-DEVD-al in the absence or in the presence of staurosporine (STS, 1M), etoposide (ETO, 50M), or ceramide C2 (CER, 100M) for the indicated times. 

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "K1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "(squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205120:Square [Spatial Concept]
   966   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "T1 (circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "or with Ac-DEVD-al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1412573:AC [Gene or Genome]
   760   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3539770:AC [Gene or Genome]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or in the presence of staurosporine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(STS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037556:STS [Lipid,Pharmacologic Substance]

Phrase: "1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(ETO,"

Phrase: "50M"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "ceramide C2 (CER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0237504:CER [Intellectual Product]

Phrase: "100M"

Phrase: ")"

Phrase: "for the indicated times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.111: After incubations, caspase activity was assayed as detailed under "Experimental Procedures." 

Phrase: "After incubations,"

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed under ""Experimental Procedures."""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.112: Each point corresponds to the Ac-DEVD-al-sensitive Ac-DEVD-AMC hydrolyzing activity and is the mean of duplicate determinations of 3independent experiments. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "corresponds"

Phrase: "to the Ac-DEVD-al-sensitive Ac-DEVD-AMC hydrolyzing activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]
   704   C0674974:Ac-DEVD-AMC [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "is"

Phrase: "the mean of duplicate determinations of 3independent experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0444504:Mean [Quantitative Concept]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.113: The measurement of Ac-DEVD-al-sensitive caspase activity is a specific cell response that can be likely ascribed to programmed cell death. 

Phrase: "The measurement of Ac-DEVD-al-sensitive caspase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0242485:Measurement [Functional Concept]

Phrase: "is"

Phrase: "a specific cell response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "ascribed to programmed cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0162638:Programmed Cell Death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: In order to examine a more global response, we studied the etoposide and staurosporine-induced vulnerability of mock-transfected TSM1 neurons and compared it with those of T1 and K1 clones. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "examine"

Phrase: "a more global response,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "staurosporine-induced vulnerability of mock-transfected TSM1 neurons"

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "it with those of T1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1413227:T1 [Gene or Genome]

Phrase: "and"

Phrase: "K1 clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.115: Both effectors trigger an ~50% decrease in cell viability of mock-transfected neurons (Fig. 7). 

Phrase: "Both effectors"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "an ~50% decrease in cell viability of mock-transfected neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0007620:Cell Viability [Cell Function]
   739   C0443348:viability [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: Wild-type -synuclein clearly enhances neurons viability in response to staurosporine (71.2%, n=14,p<0.001compared with mock) and etoposide (75.8%, n=8,p<0.001,see Fig. 7, A and B). 

Phrase: "Wild-type -synuclein clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "neurons viability in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443348:viability [Qualitative Concept]

Phrase: "to staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(71.2%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "n=14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p<0.001compared with mock"

Phrase: ")"

Phrase: "and"

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(75.8%,"

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.117: Interestingly, K1 clone viability is highly affected by both agents and appears even more susceptible than mock-transfected cells (32% staurosporine, n=14,p<0.01and 23% etoposide, n=8,p<0.001,see Fig. 7, A and B). 

Phrase: "Interestingly,"

Phrase: "K1 clone viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443348:viability [Qualitative Concept]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "affected by both agents"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "even more susceptible than mock-transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0231204:Susceptible [Functional Concept]
   748   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "(32% staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "n=14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p<0.01and 23% etoposide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]
   708   C0795725:P-23 [Organic Chemical,Pharmacologic Substance]

Phrase: "n=8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.118: View larger version (11K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 7.  

Phrase: "7."
Processing 00000000.tx.120: Effect of staurosporine and etoposide on the viability of TSM1 neurons expressing wild-type and mutated -synucleins. 

Phrase: "Effect of staurosporine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "etoposide on the viability of TSM1 neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synucleins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.121: Mock-transfected TSM1 neurons (Mock), K1, or T1 clones were cultured in the absence (control) or in the presence of staurosporine (A, 1M, 2h) or etoposide (B, 50M, 24h). 

Phrase: "Mock-transfected TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: ")"

Phrase: ","

Phrase: "K1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "or"

Phrase: "T1 clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "cultured in the absence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or in the presence of staurosporine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(A,"

Phrase: "1M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "etoposide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "50M,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.122: Cell viability was measured with the XTT assay as detailed under "Experimental Procedures" and is expressed as the percentage of the control taken as 100.Bars are the meansS.E. of duplicate determinations of 14-18 independent experiments. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured with the XTT assay"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "detailed under ""Experimental Procedures"""
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1522508:Detailed [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1561567:detail [Functional Concept]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "expressed as the percentage of the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0243148:control [Qualitative Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "taken as 100.Bars"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1707156:BARS [Gene or Genome]
   770   C1883727:Taken [Conceptual Entity]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]
   737 E C1515187:Take [Health Care Activity]

Phrase: "are"

Phrase: "the meansS.E."

Phrase: "of duplicate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "of 14-18 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.123: **, p<0.001; 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.124: *, p<0.01compared with mock-transfected cells.  

Phrase: "*,"

Phrase: "p<0.01compared with mock-transfected cells."
Processing 00000000.tx.125: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES A dense network of histological and biochemical evidence indicates that programmed cell death could contribute to Parkinson's disease neuropathology. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A dense network of histological"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1513822:Network [Professional or Occupational Group]
   760   C1705739:Network [Manufactured Object]
   760   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "biochemical evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that programmed cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "contribute to Parkinson's disease neuropathology."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C1540677:neuropathology disease [Pathologic Function]
           neuropathology
   760   C0012634:Disease [Disease or Syndrome]
   760   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   760   C1555824:Neuropathology [Intellectual Product]
   760   C1880177:Contribute [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.126: Thus, Mochizuki et al. 

Phrase: "Thus,"

Phrase: "Mochizuki et al."
Processing 00000000.tx.127: (15) reported on the presence of nick end-labeled apoptotic stigmata in the midbrains of late and early onset affected patients. 

Phrase: "(15"

Phrase: ")"

Phrase: "reported on the presence of nick end-labeled apoptotic stigmata"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   739   C0277787:Stigmata [Finding]
   739   C0376293:Stigmata [Phenomenon or Process]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0444930:End [Spatial Concept]
   739   C0684224:Reported [Intellectual Product]
   739   C0700287:Reported [Health Care Activity]
   739   C1516044:Apoptotic [Qualitative Concept]
   739   C1708632:Labeled [Qualitative Concept]
   739   C2746065:End [Temporal Concept]
   739   C3496591:Reported [Clinical Attribute]
   706 E C0181496:Label [Manufactured Object]
   706 E C2827499:Label [Governmental or Regulatory Activity]
   706 E C3273238:Report [Intellectual Product]

Phrase: "in the midbrains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025462:Midbrains [Body Part, Organ, or Organ Component]
   966 E C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "of late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "and"

Phrase: "early onset affected patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0522476:affected patients [Qualitative Concept]
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.128: This was confirmed by a morphological study showing typical degenerating neurons in the nigro-striatal area (16, 17). 

Phrase: "This"

Phrase: "was"

Phrase: "confirmed by a morphological study"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0543482:morphological [Spatial Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0750484:Confirmed [Idea or Concept]
   760   C2603343:Study [Research Activity]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "typical degenerating neurons in the nigro-striatal area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027882:Neurons [Cell]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.129: Several animal models used to study Parkinson's disease pathology led to the in situ detection of apoptotic nuclei (18) as it can also be evidenced in several cell models including human neuroblastoma (19), PC12 (20, 21), or primary cultures of mesencephalic neurons (21). 

Phrase: "Several animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599779:Models, Animal [Animal]
   827   C0003062:Animal [Animal]
   827   C3161035:Models [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "Parkinson's disease pathology"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "led to the in situ detection of apoptotic nuclei"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   764   C0444498:In situ [Spatial Concept]
   764   C2751835:Apoptotic nuclei [Finding]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1516044:Apoptotic [Qualitative Concept]
   742   C1708698:LED [Manufactured Object]
   708   C0007610:Nucleus [Cell Component]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(18"

Phrase: ")"

Phrase: "as"

Phrase: "it"

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "evidenced in several cell models"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3161035:Models [Intellectual Product]
   726   C0332120:Evidence [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "human neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027819:Neuroblastoma [Neoplastic Process]
   861   C0700095:neuroblastoma [Neoplastic Process]
   861   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "primary cultures of mesencephalic neurons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0010453:Cultures [Idea or Concept]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.130: Several biochemical clues of a link between Parkinson's disease and actors of the apoptotic pathways have also been reported. 

Phrase: "Several biochemical clues of a link"

Phrase: "between Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "actors of the apoptotic pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0335083:Actors [Professional or Occupational Group]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.131: Bcl2 expression is modulated in Parkinson's disease-affected brains (22, 23). 

Phrase: "Bcl2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "modulated in Parkinson's disease-affected brains"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   767   C0006111:Brain Disease [Disease or Syndrome]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0392760:Affected [Functional Concept]
   753   C0443264:Modulated [Spatial Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.132: Prostate apoptosis response-4 levels increase in neurons of the dopaminergic pathway after exposure of mice or monkeys to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (24), a neurotoxin classically used to elicit dopaminergic neurons cell death. 

Phrase: "Prostate apoptosis response-4 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   836   C1547597:Response level [Idea or Concept]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771   C1335191:prostate apoptosis response-4 [Gene or Genome]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "increase in neurons of the dopaminergic pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1512035:Dopaminergic Neurons [Cell]
   748   C0027882:Neurons [Cell]
   748   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C0442805:Increase [Functional Concept]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "or"

Phrase: "monkeys to 1-methyl-4-phenyl-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0026447:Monkeys [Mammal]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-tetrahydropyridine"

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "a neurotoxin classically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027934:Neurotoxin [Hazardous or Poisonous Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "dopaminergic neurons cell death."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   906   C2754100:neuron cell death [Cell Function]
           neuron death
   875   C1512035:Dopaminergic cell [Cell]
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.133: Furthermore, oxidative stress seems to contribute to the Parkinson's disease pathogenesis (25), as corroborated by subsequent works demonstrating that a mitochondrial impairment (26) and ceramide-dependent apoptosis (27) occurred in the neuronal cell line NS20Y as well as in PC12 cells. 

Phrase: "Furthermore,"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the Parkinson's disease pathogenesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1880177:Contribute [Activity]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "corroborated by subsequent works"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0043227:works [Occupational Activity]
   770   C0332282:Subsequent [Temporal Concept]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "a mitochondrial impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "ceramide-dependent apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(27"

Phrase: ")"

Phrase: "occurred in the neuronal cell line NS20Y"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:Line [Spatial Concept]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1709305:Occurred [Activity]
   748   C1948049:Cell [Spatial Concept]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "as well as in PC12 cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0085262:PC12 Cells [Cell]
           PC-12
   783   C2347578:Cells/well [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C0205170:Well [Qualitative Concept]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C3146287:Well [Manufactured Object]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.134: We previously used TSM1 neurons to establish a protein-kinase A-regulated -secretase cleavage of -amyloid precursor protein (-APP) (28, 29). 

Phrase: "We previously used TSM1 neurons to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a protein-kinase A-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulated -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "secretase cleavage of -amyloid precursor protein (-APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.135: This cell model also allowed us to confirm the unusual phenotypic alteration triggered by a novel mutation of -APP associated with familial form of Alzheimer's disease in agreement with that seen in HEK293 cells (13). 

Phrase: "This cell model also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the unusual phenotypic alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "triggered by a novel mutation of -APP"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   781   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1444748:Triggered by [Qualitative Concept]
           Trigger
   764   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205314:Novel [Temporal Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0679622:novel [Intellectual Product]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1709634:Precursor [Idea or Concept]
   708   C0032930:Trigger [Clinical Attribute]

Phrase: "associated with familial form of Alzheimer's disease"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   804   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1832428:Familial form [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
   738 E C0344339:disease family [Finding]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with that"

Phrase: "seen in HEK293 cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.136: Altogether, these data indicate that TSM1 neurons represent a most suitable cell system from central origin to examine the putative function of protein candidates involved in neurodegenerative disease. 

Phrase: "Altogether,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a most suitable cell system from central origin to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0449913:System [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   712   C0559522:Genital system [Body System]
   712   C1283795:Genital system [Body System]

Phrase: "examine"

Phrase: "the putative function of protein candidates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "involved in neurodegenerative disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.137: This cell model was used to demonstrate that -synuclein could negatively control the Ac-DEVD-al-sensitive caspase activation of TSM1 neurons in response to various stimuli, the pharmacological spectrum of which strongly suggests an apoptotic rather than necrotic mechanism. 

Phrase: "This cell model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "negatively"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the Ac-DEVD-al-sensitive caspase activation of TSM1 neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1159825:Caspase Activation [Molecular Function]
   739   C1879547:Activation [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to various stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "the pharmacological spectrum of which strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883073:Spectrum [Quantitative Concept]
   753   C2827424:Spectrum [Conceptual Entity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "rather than"

Phrase: "necrotic mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.138: Of most interest is the observation that this negative control of caspase activity is fully abolished by the Ala-53 Thr mutation of -synuclein responsible for autosomic dominant forms of the disease (5). 

Phrase: "Of most interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "is"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "this negative control of caspase activity"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C1639518:% negative control [Quantitative Concept]
   790   C1947986:Negative Control [Conceptual Entity]
   753   C0205160:Negative [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]
   748   C1706449:Active Control [Research Activity]

Phrase: "is"

Phrase: "fully"

Phrase: "abolished by the Ala-53 Thr mutation of -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0026882:Mutation [Genetic Function]
   742   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "responsible for autosomic dominant forms of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: The cellular mechanism underlying the antiapoptotic function of -synuclein still remains to be elucidated. 

Phrase: "The cellular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the antiapoptotic function of -synuclein still"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.140: However, one could postulate on the involvement of the chaperoning property of -synuclein. 

Phrase: "However,"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "postulate on the involvement of the chaperoning property of -synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0871161:Property [Qualitative Concept]
   739   C1314939:Involvement [Functional Concept]
   739   C1882134:Property [Conceptual Entity]
   739   C2347695:Property [Entity]
   706   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.141: Thus, -synuclein has been shown to bind tau proteins (30) and to display the ability to interact with brain vesicles, a property that is abolished by Parkinson's disease mutations (30). 

Phrase: "Thus, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "tau proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(30"

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "interact with brain vesicles,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C1622418:vesicle [Cell Component]

Phrase: "a property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871161:Property [Qualitative Concept]
  1000   C1882134:Property [Conceptual Entity]
  1000   C2347695:Property [Entity]

Phrase: "that"

Phrase: "is"

Phrase: "abolished by Parkinson's disease mutations"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.142: Most interesting was the recent report (31) indicating that -synuclein exhibits a 40% homology with members of the 14-3-3chaperone protein family. 

Phrase: "Most interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:interesting [Mental Process]

Phrase: "was"

Phrase: "the recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "indicating"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a 40% homology with members"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "of the 14-3-3chaperone protein family."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.143: 14-3-3proteins interact with BAD, a pro-apoptotic oncogene that remains inactive when sequestered in the cytosol (32). 

Phrase: "14-3-3proteins"

Phrase: "interact with BAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205169:Bad [Qualitative Concept]

Phrase: "a pro-apoptotic oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029016:Oncogene [Gene or Genome]

Phrase: "that"

Phrase: "remains"

Phrase: "inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]

Phrase: "when"

Phrase: "sequestered in the cytosol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333312:Sequestered [Functional Concept]
   770   C1383501:Cytosol [Cell Component]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.144: To explain the antiapoptotic function of -synuclein by its chaperone activity, one could therefore envision that, under physiological conditions, wild-type -synuclein interacts with cellular intermediates of the apoptotic pathways. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "the antiapoptotic function of -synuclein by its chaperone activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "therefore"

Phrase: "envision"

Phrase: "that,"

Phrase: "under physiological conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "interacts with cellular intermediates of the apoptotic pathways."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0007634:Cellular [Cell]
   744   C0178539:Cellular [Functional Concept]
   744   C1516044:Apoptotic [Qualitative Concept]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   718   C0162638:Apoptosis Pathway [Cell Function]
   711   C0205103:Intermediate [Spatial Concept]
   711   C1550465:intermediate [Idea or Concept]
   711   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.145: In the pathology, -synuclein accumulates and aggregates as has been documented by the high concentration of the protein in Lewy bodies invading Parkinson's disease brains. 

Phrase: "In the pathology, -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulates"

Phrase: "and"

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "documented by the high concentration of the protein"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   767   C0427716:Protein concentration [Laboratory Procedure]
   767   C1304757:Protein concentration [Laboratory or Test Result]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086045:Concentration [Mental Process]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1301725:Documented [Health Care Activity]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1609436:documented [Idea or Concept]
   744   C2700149:HIGH [Intellectual Product]
   711 E C1301746:document [Intellectual Product]
   711 E C1547673:Document [Intellectual Product]

Phrase: "in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "invading"

Phrase: "Parkinson's disease brains."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]
Processing 00000000.tx.146: Under these pathological conditions, the wild-type -synuclein-mediated inhibitory tonus on caspase activity could be abolished, thereby contributing to increased cell death. 

Phrase: "Under these pathological conditions,"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the wild-type -synuclein-mediated inhibitory tonus on caspase activity"

Phrase: "could"

Phrase: "be"

Phrase: "abolished"

Phrase: ","

Phrase: "thereby"

Phrase: "contributing to increased cell death."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1880177:Contributing [Activity]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.147: This hypothesis is in agreement with the observation that aggregated -synuclein triggers cell death in human neuroblastoma cells (8). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that aggregated -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "cell death in human neuroblastoma cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007587:Cell Death [Cell Function]
           cells death
   783   C0427861:cell human [Laboratory or Test Result]
   783   C0815000:neuroblastoma cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.148: In this context, mutated -synucleins could accelerate the pathogenesis because of the absence of neuroprotection to apoptotic stimuli (our study), its higher susceptibility to aggregation (7), and its ability to trigger apoptotic cell death when aggregated (8). 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "mutated -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the pathogenesis because of the absence of neuroprotection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]

Phrase: "to apoptotic stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "("

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "its higher susceptibility to aggregation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.149: It should be noted in support of this hypothesis that at a cellular level, -synuclein is almost exclusively found to be associated with normal neurons but not with those exhibiting an apoptotic phenotype (9). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted in support of this hypothesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0183683:Support [Medical Device]
   753   C1512571:Hypothesis [Idea or Concept]
   753   C1521721:Support [Conceptual Entity]
   719   C1316572:Note [Clinical Attribute]
   719   C1317574:Note [Intellectual Product]
   719   C1369612:Note [Clinical Attribute]

Phrase: "that at a cellular level, -"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "almost exclusively"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with normal neurons"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0027882:Neurons [Cell]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "not with those exhibiting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015272:exhibiting [Intellectual Product]
   770   C1518422:Not [Functional Concept]

Phrase: "an apoptotic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.150: Some authors (33) demonstrated that in the target injury model, -synuclein expression was up-regulated, suggesting that this could correspond to a compensatory response of neurons designed to promote their survival, in agreement with a physiological antiapoptotic function. 

Phrase: "Some authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "(33"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that in the target injury model, -"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
   753   C3161035:Model [Intellectual Product]
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]

Phrase: "synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "could"

Phrase: "correspond to a compensatory response of neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0027882:Neurons [Cell]
   748   C0231186:Compensatory [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "their survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with a physiological antiapoptotic function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   827   C2986514:antiapoptotic [Chemical Viewed Functionally]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.151: It is interesting to emphasize the parallels between Parkinson's disease and Alzheimer's disease pathology. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emphasize"

Phrase: "the parallels between Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C2348042:Parallel [Qualitative Concept]
   726   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "Alzheimer's disease pathology."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.152: Thus, familial Alzheimer's disease cases are mostly due to mutations located on two proteins, namely the -amyloid precursor protein and presenilin 1(for reviews see Refs. 

Phrase: "Thus,"

Phrase: "familial Alzheimer's disease cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "are"

Phrase: "mostly due to mutations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0026882:Mutations [Genetic Function]
   770   C0750554:mostly [Idea or Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "located on two proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205448:Two [Quantitative Concept]

Phrase: "namely"

Phrase: "the -amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "for reviews"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.153: 34 and 35). 

Phrase: "34"

Phrase: "and"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.154: It has been demonstrated that wild-type presenilin 1displays antiapoptotic function that is abolished by presenilin 1bearing familial Alzheimer's disease mutations (for reviews see Refs. 36 and 37). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that wild-type presenilin 1displays antiapoptotic function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   799   C0031843:function [Physiologic Function]
   799   C0542341:Function [Functional Concept]
   799   C0700205:FUNCTION [Classification]
   799   C1705273:Function [Intellectual Product]
   799   C2986514:antiapoptotic [Chemical Viewed Functionally]
   727 E C0205245:Functional [Functional Concept]
   727 E C2700217:Functional [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "abolished by presenilin 1bearing familial Alzheimer's disease mutations"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   800   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0277558:Familial disease [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015576:familial [Family Group]
   744   C0026882:Mutations [Genetic Function]
   744   C0241888:Familial [Functional Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   731 E C0344339:disease family [Finding]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "for reviews"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.155: Identical observations indicate that -APP confer resistance to p53-induced cell death, but the familial Alzheimer's disease-associated V717I -APP did not (38). 

Phrase: "Identical observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that -APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "confer"

Phrase: "resistance to p53-induced cell death,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332325:Resistant to [Functional Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "but"

Phrase: "the familial Alzheimer's disease-associated V717I -APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   885   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   883   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709634:Precursor [Idea or Concept]

Phrase: "did"

Phrase: "not (38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.156: Our work opens a possible track to slow down or stop the progression of the neurodegeneration taking place in Parkinson's disease. 

Phrase: "Our work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "opens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "a possible track to slow down"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040594:Track [Manufactured Object]

Phrase: "or"

Phrase: "stop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1947925:Stop [Activity]
  1000   C2746065:Stop [Temporal Concept]

Phrase: "the progression of the neurodegeneration taking place"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.157: Thus, one can envision the design of peptides or chemically designed agents displaying -synuclein anti-aggregating properties. 

Phrase: "Thus,"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "can"

Phrase: "envision"

Phrase: "the design of peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "or"

Phrase: "chemically designed agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "displaying -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "anti-aggregating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregating [Qualitative Concept]

Phrase: "properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]
Processing 00000000.tx.158: According to our hypothesis, such effectors may prevent -synuclein deposits and should maintain it as a physiological antiapoptotic modulator.  

Phrase: "According to our hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "such effectors"

Phrase: "may"

Phrase: "prevent -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "synuclein deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "and"

Phrase: "should"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "it"

Phrase: "as"

Phrase: "a physiological antiapoptotic modulator."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709060:Modulator [Manufactured Object]
Processing 00000000.tx.159: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.160: Patrick Auberger for critical reading of the manuscript. 

Phrase: "Patrick Auberger for critical reading of the manuscript."
Processing 00000000.tx.161: We sincerely thank Allelix Biopharmaceutical Inc. 

Phrase: "We sincerely"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Allelix Biopharmaceutical Inc."
Processing 00000000.tx.162: (Missisauga, Canada) for TSM1 cell line.  

Phrase: "(Missisauga,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "for TSM1 cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.163: FOOTNOTES * This work was supported in part by INSERM, CNRS, and the French Alzheimer's Research Network supported by Aventis Pharma.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by INSERM,"

Phrase: "CNRS,"

Phrase: "and"

Phrase: "the French Alzheimer's Research Network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1513822:Network [Professional or Occupational Group]
   812   C1705739:Network [Manufactured Object]
   812   C1882071:Network [Conceptual Entity]

Phrase: "supported by Aventis Pharma."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
Processing 00000000.tx.164: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.165: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.166: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.167: Recipient of a grant from Aventis Pharma.  

Phrase: "Recipient of a grant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709854:Recipient [Human]

Phrase: "from Aventis Pharma."
Processing 00000000.tx.168: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.169: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.170: 33493957760; 

Phrase: "33493957760"

Phrase: ";"
Processing 00000000.tx.171: Fax: 33493957708/04; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "33493957708/04"

Phrase: ";"
Processing 00000000.tx.172: E-mail: checler@ipmc.cnrs.fr. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "checler@ipmc.cnrs.fr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2348513:Fr. [Conceptual Entity]
   812   C3538902:FR [Gene or Genome]
Processing 00000000.tx.173: Published, JBC Papers in Press, May 18,2000,DOI 10.1074/jbc.M002413200  ABBREVIATIONS The abbreviations used are: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "May 18,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M002413200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.174: Ac-DEVD-al, acetyl-Asp-Glu-Val-Asp-aldehyde; 

Phrase: "Ac-DEVD-al,"

Phrase: "acetyl-Asp-Glu-Val-Asp-aldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0001992:Aldehyde [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.175: 7AMC, 7-amino-4-methylcoumarin; 

Phrase: "7AMC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048508:7AMC [Organic Chemical]

Phrase: "7-amino-4-methylcoumarin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049828:7-amino-4-methylcoumarin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   902   C3659528:7-methylcoumarin [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.176: XTT, sodium 3'-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzenesulfonic acid; 

Phrase: "XTT,"

Phrase: "sodium 3'-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "[1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(phenylaminocarbonyl"

Phrase: ")-"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4-tetrazolium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "]-bis(4-methoxy-6-nitro"

Phrase: ")"

Phrase: "benzenesulfonic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0053170:benzenesulfonic acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.177: -APP, -amyloid precursor protein; 

Phrase: "-APP, -amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.178: Chaps, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.  

Phrase: "Chaps,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   966 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "(3-cholamidopropyl"

Phrase: ")"

Phrase: "dimethylammonio"

Phrase: "]-1-propanesulfonic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.179: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.180: Forno, L. 

Phrase: "Forno,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.181: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.182: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.183: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.184: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.185: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.186: 55, 259-272[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "259-272"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.187: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.188: G., Schmidt, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.189: L., Lee, V.-Y., Trojanowski, J. 

Phrase: "L., Lee,"

Phrase: "V.-Y.,"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.190: Q., Jakes, R., and Goedert, M. 

Phrase: "Q., Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.191: (1997) Nature 388, 839-840[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839-840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.192: Arima, K., Uda, K., Sunohara, N., Hirai, S., Izumiyama, Y., Tonozuka-Uehara, H., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Izumiyama,"

Phrase: "Y.,"

Phrase: "Tonozuka-Uehara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.193: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.194: 808, 93-100[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "808,"

Phrase: "93-100"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.195: Uda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. 

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukushima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Otero,"

Phrase: "D."
Processing 00000000.tx.196: A.C., Kondo, J., Ihara, Y., and Saitoh, T. 

Phrase: "A.C., Kondo,"

Phrase: "J.,"

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.197: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.198: Natl. 

Phrase: "Natl."
Processing 00000000.tx.199: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.200: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.201: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.202: 90, 11282-11286[Abstract] 5. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "11282-11286"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.203: Polymeropoulos, M. 

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.204: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.205: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.206: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnston, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnston,"

Phrase: "W."
Processing 00000000.tx.207: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.208: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.209: C., Di lorio, G., Golbe, L. 

Phrase: "C., Di lorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.210: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.211: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.212: (1997) Science 276, 2045-2047[Abstract/Free FullText] 6. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.213: Krger, R., Kuhn, W., Mller, T., Woitalla, D., Graeber, M., Ksel, S., Przuntek, H., Epplen, J. 

Phrase: "Krger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Mller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Ksel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.214: T., Schls, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schls,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.215: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.216: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.217: 18, 106-108[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "18,"

Phrase: "106-108"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.218: Narhi, L., Wood, S. 

Phrase: "Narhi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.219: J., Steavenson, S., Jiang, Y., Wu, G. 

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.220: M., Anafi, D., Kaufman, S. 

Phrase: "M."

Phrase: ","

Phrase: "Anafi,"

Phrase: "D."

Phrase: ","

Phrase: "Kaufman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.221: A., Martin, F., Sitney, K., Denis, P., Louis, J.-C., Wypych, J., Biere, A. 

Phrase: "A.,"

Phrase: "Martin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sitney,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J.-C., Wypych,"

Phrase: "J.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.222: L., and Citron, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.223: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.224: Biol. 

Phrase: "Biol."
Processing 00000000.tx.225: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.226: 274, 9843-9846[Abstract/Free FullText] 8. 

Phrase: "274,"

Phrase: "9843-9846"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.227: El-Agnaf, O. 

Phrase: "El-Agnaf,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.228: M.A., Jakes, R., Curran, M. 

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Curran,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.229: D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., and Wallace, A. 

Phrase: "D."

Phrase: ","

Phrase: "Middleton,"

Phrase: "D."

Phrase: ","

Phrase: "Ingenito,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bianchi,"

Phrase: "E.,"

Phrase: "Pessi,"

Phrase: "A.,"

Phrase: "Neill,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.230: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.231: 440, 71-75[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "440,"

Phrase: "71-75"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.232: Kholodinov, N. 

Phrase: "Kholodinov,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.233: G., Oo, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Oo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.234: F., and Burke, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Burke"

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.235: E. 

Phrase: "E."
Processing 00000000.tx.236: (1999) Neurosci. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.237: Lett. 

Phrase: "Lett."
Processing 00000000.tx.238: 275, 105-108[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "275,"

Phrase: "105-108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.239: Chun, J., and Jaenisch, R. 

Phrase: "Chun,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jaenisch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.240: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.241: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.242: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.243: 7, 304-321[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "7,"

Phrase: "304-321"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.244: Ancolio, K., Alves da Costa, C., Uda, K., and Checler, F. 

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.245: (2000) Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.246: Lett. 

Phrase: "Lett."
Processing 00000000.tx.247: 285, 79-82[CrossRef][Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "285,"

Phrase: "79-82"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.248: Kunkel, T. 

Phrase: "Kunkel,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.249: A. 

Phrase: "A."
Processing 00000000.tx.250: (1985) Proc. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.251: Natl. 

Phrase: "Natl."
Processing 00000000.tx.252: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.253: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.254: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.255: 82, 488-492[Abstract] 13. 

Phrase: "82,"

Phrase: "488-492"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 13."
Processing 00000000.tx.256: Ancolio, K., Dumanchin, C., Barelli, H., Warter, J. 

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dumanchin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Barelli,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Warter,"

Phrase: "J."
Processing 00000000.tx.257: M., Brice, A., Campion, D., Frbourg, T., and Checler, F. 

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Frbourg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.258: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.259: Natl. 

Phrase: "Natl."
Processing 00000000.tx.260: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.261: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.262: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.263: 96, 4119-4124[Abstract/Free FullText] 14. 

Phrase: "96,"

Phrase: "4119-4124"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.264: Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. 

Phrase: "Okochi,"

Phrase: "M."

Phrase: ","

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Koyama,"

Phrase: "A.,"

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Meijer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kahle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.265: J., and Haass, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.266: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.267: Biol. 

Phrase: "Biol."
Processing 00000000.tx.268: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.269: 275, 390-397[Abstract/Free FullText] 15. 

Phrase: "275,"

Phrase: "390-397"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.270: Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y. 

Phrase: "Mochizuki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Goto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.271: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.272: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.273: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.274: 137, 120-123[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "137,"

Phrase: "120-123"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.275: Ziv, I., Barzilai, A., Offen, D., Nardi, N., and Melamed, E. 

Phrase: "Ziv,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Barzilai,"

Phrase: "A.,"

Phrase: "Offen,"

Phrase: "D."

Phrase: ","

Phrase: "Nardi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Melamed,"

Phrase: "E."
Processing 00000000.tx.276: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.277: Neural Transm. 

Phrase: "Neural Transm."
Processing 00000000.tx.278: Suppl. 

Phrase: "Suppl."
Processing 00000000.tx.279: 49, 69-76[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "49,"

Phrase: "69-76"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.280: Tompkins, M. 

Phrase: "Tompkins,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.281: M., Basgall, E., Zamrini, E., and Hill, W. 

Phrase: "M."

Phrase: ","

Phrase: "Basgall,"

Phrase: "E.,"

Phrase: "Zamrini,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "W."
Processing 00000000.tx.282: (1997) Am. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.283: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.284: 150, 119-131[Abstract] 18. 

Phrase: "150,"

Phrase: "119-131"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 18."
Processing 00000000.tx.285: Tatton, N., and Kish, S. 

Phrase: "Tatton,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kish,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.286: (1997) Neuroscience 77, 1037-1048[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuroscience 77,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "1037-1048"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.287: Fall, C., and Bennett, J. 

Phrase: "Fall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Bennett,"

Phrase: "J."
Processing 00000000.tx.288: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.289: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.290: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.291: 55, 620-628[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "620-628"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.292: Offen, D., Ziv, I., Sternion, H., Melamed, E., and Hochman, A. 

Phrase: "Offen,"

Phrase: "D."

Phrase: ","

Phrase: "Ziv,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sternion,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Melamed,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Hochman,"

Phrase: "A."
Processing 00000000.tx.293: (1996) Exp. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.294: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.295: 141, 32-39[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "141,"

Phrase: "32-39"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.296: Ruberg, M., France-Lanord, V., Brugg, B., Lambeng, N., Michel, P., Anglade, P., Hunot, S., Damier, P., Faucheux, B., Hirsch, E., and Agid, Y. 

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "France-Lanord,"

Phrase: "V.,"

Phrase: "Brugg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lambeng,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Michel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Anglade,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hunot,"

Phrase: "S."

Phrase: ","

Phrase: "Damier,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Faucheux,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hirsch,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Agid,"

Phrase: "Y."
Processing 00000000.tx.297: (1997) Rev. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.298: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.299: (Paris) 153, 499-508[Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "(Paris"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: ")"

Phrase: "153,"

Phrase: "499-508"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.300: Mogi, M., Harada, M., Kondo, T., Mizuno, Y., Narabayashi, H., Riederer, P., and Nagatsu, T. 

Phrase: "Mogi,"

Phrase: "M."

Phrase: ","

Phrase: "Harada,"

Phrase: "M."

Phrase: ","

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Narabayashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Riederer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Nagatsu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.301: (1996) Neurosci. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.302: Lett. 

Phrase: "Lett."
Processing 00000000.tx.303: 215, 137-139[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "215,"

Phrase: "137-139"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.304: Marshall, K., Daniel, S., Cairns, N., Jenner, P., and Halliwell, B. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Daniel,"

Phrase: "S."

Phrase: ","

Phrase: "Cairns,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Halliwell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.305: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.306: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.307: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.308: Commun. 

Phrase: "Commun."
Processing 00000000.tx.309: 240, 84-87[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "240,"

Phrase: "84-87"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.310: Duan, W., Zhang, Z., Gash, D., and Mattson, M. 

Phrase: "Duan,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Gash,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.311: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.312: (1999) Ann. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.313: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.314: 46, 587-597[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "46,"

Phrase: "587-597"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.315: Jenner, P., and Olanow, C. 

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C."
Processing 00000000.tx.316: (1996) Neurology 47, 161-170 26. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurology 47,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "161-170 26."
Processing 00000000.tx.317: Merad-Boudia, M., Nicole, A., Santiard-Baron, D., Saille, C., and Ceballos-Picot, I. 

Phrase: "Merad-Boudia,"

Phrase: "M."

Phrase: ","

Phrase: "Nicole,"

Phrase: "A.,"

Phrase: "Santiard-Baron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331778:Baron [Health Care Related Organization]

Phrase: "D."

Phrase: ","

Phrase: "Saille,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Ceballos-Picot,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2949559:Picot [Pharmacologic Substance]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.318: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.319: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.320: 56, 645-655[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "56,"

Phrase: "645-655"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.321: France-Lanord, V., Brugg, B., Michel, P., Agid, Y., and Ruberg, M. 

Phrase: "France-Lanord,"

Phrase: "V.,"

Phrase: "Brugg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Michel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Ruberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.322: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.323: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.324: 69, 1612-1621[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "1612-1621"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.325: Marambaud, P., Chevallier, N., Ancolio, K., and Checler, F. 

Phrase: "Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chevallier,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.326: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.327: Med. 

Phrase: "Med."
Processing 00000000.tx.328: 4, 715-723[Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "4,"

Phrase: "715-723"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.329: Marambaud, P., Ancolio, K., Alves da Costa, C., and Checler, F. 

Phrase: "Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.330: (1999) Br. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.331: J.

Phrase: "J."
Processing 00000000.tx.332: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.333: 126, 1186-1190[Abstract/Free FullText] 30. 

Phrase: "126,"

Phrase: "1186-1190"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.334: Jensen, H., P., Hager, H., Nielsen, M. 

Phrase: "Jensen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hager,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: S., Hojrup, P., Gliemann, J., and Jakes, R. 

Phrase: "S."

Phrase: ","

Phrase: "Hojrup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gliemann,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.336: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.337: Biol. 

Phrase: "Biol."
Processing 00000000.tx.338: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.339: 274, 25481-25485[Abstract/Free FullText] 31. 

Phrase: "274,"

Phrase: "25481-25485"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.340: Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., and Wolozin, B. 

Phrase: "Ostrerova,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.341: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.342: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.343: 19, 5782-5791[Abstract/Free FullText] 32. 

Phrase: "19,"

Phrase: "5782-5791"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.344: Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. 

Phrase: "Zha,"

Phrase: "J.,"

Phrase: "Harada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "E.,"

Phrase: "Jockel,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Korsmeyer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.345: J. 

Phrase: "J."
Processing 00000000.tx.346: (1996) Cell 87, 619-628[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 87,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "619-628"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.347: Kholodilov, N. 

Phrase: "Kholodilov,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.348: G., Neystat, M., Oo, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Neystat,"

Phrase: "M."

Phrase: ","

Phrase: "Oo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.349: F., Lo, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.350: E., Larsen, K. 

Phrase: "E.,"

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: E., Sulzer, D., and Burke, R. 

Phrase: "E.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Burke"

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.352: E. 

Phrase: "E."
Processing 00000000.tx.353: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.354: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.355: 73, 2586-2599[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "73,"

Phrase: "2586-2599"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.356: Van Broeckhoven, C. 

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.357: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.358: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.359: 11, 230-232[Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "11,"

Phrase: "230-232"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.360: Hutton, M., and Hardy, J. 

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.361: (1997) Hum. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.362: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.363: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.364: 6, 1639-1646[Abstract/Free FullText] 36. 

Phrase: "6,"

Phrase: "1639-1646"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.365: Haass, C. 

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.366: (1997) Neurons 18, 687-690[CrossRef][Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurons 18,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "687-690"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.367: Checler, F. 

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.368: (1999) IUBMB Life 48, 33-39[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "(1999"

Phrase: ")"

Phrase: "IUBMB Life 48,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "33-39"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.369: Xu, X., Yang, D., Wyss-Coray, T., Yan, J., Gan, L., and Mucke, L. 

Phrase: "Xu,"

Phrase: "X.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yan,"

Phrase: "J.,"

Phrase: "Gan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.370: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.371: Natl. 

Phrase: "Natl."
Processing 00000000.tx.372: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.373: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.374: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.375: 22, 7547-7552[CrossRef] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "22,"

Phrase: "7547-7552"

Phrase: "[CrossRef"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

